ARBs for cardiovascular and renal protection in high-risk patients.
作者信息
Aalbers J
出版信息
Cardiovasc J Afr. 2011 Jul-Aug;22(4):224.
PMID:21881697
Abstract
摘要
相似文献
1
ARBs for cardiovascular and renal protection in high-risk patients.
Cardiovasc J Afr. 2011 Jul-Aug;22(4):224.
2
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?ONTARGET、TRANSCEND和PROFESS——澄清、混淆还是误导？
Blood Press. 2009;18(1-2):4-6. doi: 10.1080/08037050902742282.
3
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?替米沙坦与ONTARGET试验中的卒中减少：降压之外的获益？
Cerebrovasc Dis. 2008;26(5):563-4. doi: 10.1159/000164555. Epub 2008 Oct 21.
4
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.雷米普利和替米沙坦对血清钾的影响及其与心血管和肾脏事件的关联：ONTARGET试验结果
Eur J Prev Cardiol. 2014 Mar;21(3):299-309. doi: 10.1177/2047487313510678. Epub 2013 Nov 4.
5
[New studies on hypertension of great significance to clinical practice. Also very old persons benefit from blood pressure reduction].
Lakartidningen. 2008;105(19):1382-4.
6
[Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].
MMW Fortschr Med. 2007 Dec 6;149(49-50):52-3.
7
[Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].[肾素-血管紧张素系统双重阻断在高血压治疗中的应用：可行]
Dtsch Med Wochenschr. 2012 Nov;137(48):2498. doi: 10.1055/s-0032-1327303. Epub 2012 Nov 20.
8
[In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].在曼海姆举行的德国心脏病学会（DKG）第72届年会上展示：“目标治疗”——迄今为止关于高血压患者心血管预防的最大规模研究项目。
MMW Fortschr Med. 2006 Jun 29;148(26):50-1.
9
ONTARGET proves telmisartan efficacy compared to ramipril in cardiovascular protection of patients at high risk and without heart failure.
Cardiovasc J Afr. 2008 Mar-Apr;19(2):108-9; discussion 109-10.
10
[Treatment of patients at high cardiovascular risk: confirmation and surprising results of the ONTARGET-Study].
Praxis (Bern 1994). 2008 May 14;97(10):559-62. doi: 10.1024/1661-8157.97.10.559.
Zotero 插件